Court Orders Aussie ISPs to Block Dozens of Pirate Sites

 Posted by on August 18, 2017  Comments Off on Court Orders Aussie ISPs to Block Dozens of Pirate Sites
Aug 182017
 

[Ernesto for TorrentFreak. Link (CC-BY-NC)] Following two new court orders issued today, Australian Internet providers must block dozens of additional pirate sites. The new blockades were requested by Foxtel and Village Roadshow, and cover many of the most used pirate sources, including Gomovies, RARBG, 1337x and EZTV. Creative Content Australia warns that people who bypass the blocks could easily run into malware, viruses and other nastiness.

Rather than taking site operators to court, copyright holders increasingly demand that Internet providers should block access to ‘pirate’ domains.

As a result, courts all around the world have ordered ISPs to block subscriber access to various pirate sites. Continue reading »

Share
Jul 122017
 

[Mark Schweizer for IP Kat, Link (CC-BY)] According to its media release of 11 July 2017, the German Federal Court of Justice confirmed the decision of the Federal Patent Court granting Merck a compulsory license to EP 1 422 218 owned by Shionogi. This allows Merck the continued distribution of its antiretroviral drug Isentress, an approved medication for treatment of HIV-patients, on the German market.

The case is highly unusual not only because compulsory licenses are exceptionally rarely granted under German law, but also because the license was granted in preliminary proceedings, which is a first. Continue reading »

Share

Sen. Wyden: “NAFTA 2.0 Must Take a Balanced Approach to Copyright”

 Posted by on July 6, 2017  Comments Off on Sen. Wyden: “NAFTA 2.0 Must Take a Balanced Approach to Copyright”
Jul 062017
 

Inside U.S. Trade reports on a Capitol Hill event on digital trade and the NAFTA renegotation at which Sen. Wyden made the following remark regarding copyright: “NAFTA 2.0 must take a balanced approach to copyright that ensures the free flow of ideas around the world and allows American companies to continue to compete and win across the globe. Our agreements should enshrine a copyright system that looks to the future, not one that prevents computer researchers from doing their jobs or locks in restrictive copyright rules.”

Click here for the full story on insidetrade.com.

Share

EU Parliament Adopts Marrakesh Treaty; Blind Union Prepared To Fight Publisher ‘Compensation’

 Posted by on July 6, 2017  Comments Off on EU Parliament Adopts Marrakesh Treaty; Blind Union Prepared To Fight Publisher ‘Compensation’
Jul 062017
 

Monika Ermert, IP-Watch, Link (CC-BY-NC-SA)

The European Parliament today with over 600 votes adopted the legal instruments to ratify the Marrakesh Treaty on access to reading material for the visually impaired. The treaty, adopted by the members of the World Intellectual Property Organization in 2013 and effective since last year, has been subject of controversies due to lobbying from publishers in the European Union, members of Parliament said today in Strasbourg before the vote. EU member states after today’s vote have one year to implement. Continue reading »

Share

Drug Price Gouging: Int’l Union of Operating Engineers Stationary Engineers Local 39 Health & Welfare Trust Fund et al v. Celgene

 Posted by on July 5, 2017  Comments Off on Drug Price Gouging: Int’l Union of Operating Engineers Stationary Engineers Local 39 Health & Welfare Trust Fund et al v. Celgene
Jul 052017
 

[by Zhao Zhao] On June 14th, 2017, the International Union of Operating Engineers Stationary Engineers Local 39 Health and Welfare Trust Fund, The Detectives’ Endowment Association, Inc., and David Mitchell (“Plaintiffs”) filed a class action antitrust complaint against Celgene Corporation (“Celgene”) over Celgene’s alleged exclusion of competition from the market for two drugs: thalidomide and lenalidomide. Celgene sells them under the brands Thalomid and Revlimid for treating leprosy and multiple myeloma. Continue reading »

Share

Crowdfunding Campaign Seeks to Help Diego Gómez, a Colombian Conservation Biologist Prosecuted for Sharing a Research Online

 Posted by on June 14, 2017  Comments Off on Crowdfunding Campaign Seeks to Help Diego Gómez, a Colombian Conservation Biologist Prosecuted for Sharing a Research Online
Jun 142017
 

[María Juliana Soto, Karisma, Link (CC-BY)] Karisma Foundation, a Colombian civil society organization, is launching a crowdfunding campaign to support Diego Gómez, a biologist accused of copyright infringement for sharing a scientific research online.

When he was a college student at Universidad del Quindío, Diego uploaded a thesis from a colleague at Universidad Nacional de Colombia on the document platform Scribd (citing the author’s name). He also shared it with several of his peers in social media. Continue reading »

Share

Time to Unveil the Costs of Drugs

 Posted by on June 11, 2017  Comments Off on Time to Unveil the Costs of Drugs
Jun 112017
 

Tabitha Ha, Stop AIDS, Link

In the past month, I joined two major global gatherings for multiple stakeholders, including high-level government representatives, to tackle the issue of high drug prices as well as access to medicines more broadly. What struck me were the overwhelming calls for transparency, as a recognised democratic principle, to underpin the research and development (R&D) of medicines, especially when it comes to the costs of R&D, drug prices and being able to trace public funds involved in R&D.

The Fair Pricing Forum, held by the Netherlands and the World Health Organisation (WHO) in early May was notably attended by many governments from high-income countries who are increasingly struggling with the burden of high drug prices. Later in May, thousands of delegates descended on Geneva for the 70th World Health Assembly, where the debate on access to medicines and R&D continued to rage as part of the formal proceedings and in several side events. Continue reading »

Share

US Supreme Court Adopts International Exhaustion For Patents

 Posted by on June 4, 2017  Comments Off on US Supreme Court Adopts International Exhaustion For Patents
Jun 042017
 

Paving the way for parallel imports to exert downward pressure on domestic pharmaceutical (and other) prices

[Frederick M Abbott*, IP Watch, Link (CC-BY-SA)] The Supreme Court of the United States on May 30, 2017 adopted a rule of international exhaustion of patent rights for the United States in Impression Products v. Lexmark International, No. 15-1189. The near-unanimous decision authored by Chief Justice Roberts is unambiguous and unequivocal.[1] The Court paid short shrift to contrary decisions of the Court of Appeals for the Federal Circuit in Jazz Photo Corp. v. International Trade Commission, 264 F. 3d 1094 (Fed. Cir. 2001) and in this case on certiorari, Lexmark International v. Impression Products, 816 F.3d 721 (Fed. Cir. 2016). Continue reading »

Share

¡Diego Gómez es Declarado Inocente!

 Posted by on May 25, 2017  Comments Off on ¡Diego Gómez es Declarado Inocente!
May 252017
 

[Fundación Karisma, Link (CC-BY-SA)]  Hoy, después de más de tres años de iniciado el proceso penal, el Juzgado 49 Penal del Circuito dictó sentido del fallo a favor del biólogo Diego Gómez, en un proceso penal que habría podido significarle de 4 a 8 años de cárcel y una multa millonaria por compartir un documento académico en línea.

El caso comenzó en 2014 cuando la fiscalía presentó cargos contra Gómez. Unos años atrás, cuando era estudiante de biología de la Universidad de Quindío en Colombia, Gómez compartió en internet una tesis de maestría de la Universidad Nacional que encontró útil para su grupo de estudio. Continue reading »

Share

Colombian Court Acquits Diego Gómez of Criminal Charges for Sharing a Research Paper Online

 Posted by on May 25, 2017  Comments Off on Colombian Court Acquits Diego Gómez of Criminal Charges for Sharing a Research Paper Online
May 252017
 

Timothy Vollmer, Creative Commons, Link (CC-BY)

Diego Gómez, the Colombian student who for the last three years has been prosecuted for sharing an academic paper online, has been cleared of criminal charges. The decision was delivered today by a judge in the Bogotá Circuit Criminal Court.

In 2014 Diego was a student in conservation and wildlife management, with poor access to many of the resources and databases that would help him conduct his research. Diego found and shared a academic paper online so that others could read and learn from it, just as he did. Gómez was prosecuted for copyright infringement, and faced up to eight years in prison. Continue reading »

Share

WHO Members Urged To Support Resolution Delinking Cancer Drug Prices From R&D Costs

 Posted by on May 3, 2017  Comments Off on WHO Members Urged To Support Resolution Delinking Cancer Drug Prices From R&D Costs
May 032017
 

[Catherine Saez, Intellectual Property Watch, Link (CC-BY-NC-SA)] A group of civil society organisations and health experts have sent a letter to delegates to this month’s annual World Health Assembly urging support for a study on the delinkage of the costs of research and development from the prices of cancer medicines. Member states reportedly met on the issue today and are still undecided. Continue reading »

Share

I-MAK Challenges Validity of Remaining Hepatitis C Drug Patent in China

 Posted by on April 24, 2017  Comments Off on I-MAK Challenges Validity of Remaining Hepatitis C Drug Patent in China
Apr 242017
 

[Initiative for Medicines, Access & Knowledge press release, Link (CC-BY)] In a move that could strike down barriers to treatment for the exploding hepatitis C epidemic that kills 700,000 people every year, attorneys and scientists from the Initiative for Medicines, Access & Knowledge (I-MAK) filed a legal challenge against Gilead’s (NASDAQ:GILD) remaining patent for the hepatitis C medicine sofosbuvir in China. Branded as Sovaldi®, this patent covers the sofosbuvir base compound and is founded on previously published techniques, and does not meet the legal criteria for a patent. This new filing follows another legal challenge filed by I-MAK in 2015, which helped result in a rejection in June 2015 by China’s State Intellectual Property Office (SIPO) on the other critical patent application on sofosbuvir. SIPO found that this patent, covering the prodrug that activates the otherwise inactive base compound in the body, did not deserve a patent under the law. Continue reading »

Share